Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Immune Response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons.

Esmail H. et al, (2018), Annu Rev Immunol, 36, 603 - 638

Tuberculosis Infectiousness and Host Susceptibility.

Turner RD. et al, (2017), J Infect Dis, 216, S636 - S643

Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF Therapy.

Esmail H. and Wilkinson RJ., (2017), Ann Am Thorac Soc, 14, 621 - 623

From latent to patent: rethinking prediction of tuberculosis.

Cobelens F. et al, (2017), Lancet Respir Med, 5, 243 - 244

Tuberculosis is changing.

Walker TM. et al, (2017), Lancet Infect Dis, 17, 359 - 361

TB is changing

Walker TM. et al, (2017), Lancet Infectious Diseases

THE UK'S IMPORTED FEVER SERVICE DURING THE EBOLA EPIDEMIC: A CENTRALIZED ADVICE AND DIAGNOSTIC UNIT FOR IMPORTED INFECTIONS

McGregor A. et al, (2015), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 93, 358 - 359

The ongoing challenge of latent tuberculosis.

Esmail H. et al, (2014), Philos Trans R Soc Lond B Biol Sci, 369

Detection and treatment of subclinical tuberculosis.

Robertson BD. et al, (2012), Tuberculosis (Edinb), 92, 447 - 452

Reactivation or re-infection?

Esmail H., (2011), Int J Tuberc Lung Dis, 15

Is MRSA admission bacteraemia community-acquired? A case control study.

Miller R. et al, (2008), J Infect, 56, 163 - 170

Load More